JP Morgan Chase & Co’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.35M | Sell |
|
|||||
|
2025
Q2 | $34.2M | Sell |
|
|||||
|
2025
Q1 | $30.7M | Buy |
|
|||||
|
2024
Q4 | $33.4M | Sell |
|
|||||
|
2024
Q3 | $76.1M | Sell |
|
|||||
|
2024
Q2 | $76.6M | Sell |
|
|||||
|
2024
Q1 | $72.3M | Sell |
|
|||||
|
2023
Q4 | $56.6M | Buy |
|
|||||
|
2023
Q3 | $61.1M | Sell |
|
|||||
|
2023
Q2 | $70.6M | Buy |
|
|||||
|
2023
Q1 | $27.5M | Buy |
|
|||||
|
2022
Q4 | $33.2M | Sell |
|
|||||
|
2022
Q3 | $42M | Buy |
|
|||||
|
2022
Q2 | $31.3M | Sell |
|
|||||
|
2022
Q1 | $95.3M | Buy |
|
|||||
|
2021
Q4 | $102M | Sell |
|
|||||
|
2021
Q3 | $196M | Sell |
|
|||||
|
2021
Q2 | $284M | Buy |
|
|||||
|
2021
Q1 | $174M | Buy |
|
|||||
|
2020
Q4 | $90.5M | Buy |
|
|||||
|
2020
Q3 | $56M | Buy |
|
|||||
|
2020
Q2 | $85.2M | Buy |
|
|||||
|
2020
Q1 | $46.8M | Buy |
|
|||||
|
2019
Q4 | $45.5M | Buy |
|
|||||
|
2019
Q3 | $24.6M | Buy |
|
|||||
|
2019
Q2 | $37.4M | Sell |
|
|||||
|
2019
Q1 | $67.1M | Buy |
|
|||||
|
2018
Q4 | $41.3M | Buy |
|
|||||
|
2018
Q3 | $131K | Sell |
|
|||||
|
2018
Q2 | $144K | Buy |
|
|||||
|
2018
Q1 | $114K | Sell |
|
|||||
|
2017
Q4 | $89K | Buy |
|
|||||
|
2017
Q3 | $95K | Sell |
|
|||||
|
2017
Q2 | $137K | Sell |
|
|||||
|
2017
Q1 | $878K | Sell |
|
|||||
|
2016
Q4 | $639K | Sell |
|
|||||
|
2016
Q3 | $4.07M | Buy |
|
|||||
|
2016
Q2 | $1.29M | Buy |
|
|||||
|
2016
Q1 | $239K | Sell |
|
|||||
|
2015
Q4 | $412K | Sell |
|
|||||
|
2015
Q3 | $2.78M | Sell |
|
|||||
|
2015
Q2 | $18M | Sell |
|
|||||
|
2015
Q1 | $19M | Buy |
|
|||||
|
2014
Q4 | $21.3M | Buy |
|
|||||
|
2014
Q3 | $8.77M | Sell |
|
|||||
|
2014
Q2 | $6.6M | Sell |
|
|||||
|
2014
Q1 | $6.12M | Buy |
|
|||||
|
2013
Q4 | $773K | Buy |
|
|||||
|
2013
Q3 | $858K | Buy |
|